PPF
RPRX icon

PFA Pension Forsikringsaktieselskab’s Royalty Pharma RPRX Stock Holding History

PFA Pension Forsikringsaktieselskab’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7M Sell
261,865
-857,046
-77% -$44.6M 0.04% 320
2026
Q1 		$53.7M Buy
1,118,911
+888
+0.1% +$38.9K 0.16% 163
2025
Q4 		$43.6M Buy
+1,118,023
New +$42.6M 0.12% 196

Other funds holding RPRX

Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Royal London Asset Management
Royal London Asset Management United Kingdom $54.3B AUM 39.21% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

PFA Pension Forsikringsaktieselskab's RPRX Position: Q2 2026 in Review

PFA Pension Forsikringsaktieselskab reduced its Royalty Pharma (RPRX) stake by 77% in Q2 2026, selling an estimated $44.6M and leaving 261,865 shares worth $14.7M. The position accounts for 0.04% of the portfolio, ranked #320.

PFA Pension Forsikringsaktieselskab first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $53.7M in Q1 2026. 464 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • PFA Pension Forsikringsaktieselskab held 261,865 shares of Royalty Pharma worth $14.7M as of Q2 2026.
  • PFA Pension Forsikringsaktieselskab sold 857,046 Royalty Pharma shares in Q2 2026, an estimated $44.6M.
  • Royalty Pharma made up 0.04% of PFA Pension Forsikringsaktieselskab's portfolio in Q2 2026, its #320 holding.
  • PFA Pension Forsikringsaktieselskab first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
  • PFA Pension Forsikringsaktieselskab's Royalty Pharma position peaked at $53.7M in Q1 2026.
  • 464 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on PFA Pension Forsikringsaktieselskab's 13F filing for Q2 2026, filed 12 Aug 2026.